摘要:
The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of primary negative symptoms of schizophrenia and/or predominantly negative symptoms of schizophrenia.
摘要:
New methods for the refolding of recombinant granulocyte colony stimulating factor (G-CSF) from inclusion bodies are disclosed. The methods comprise two refolding steps. In particular, the methods comprise the solubilizing of G-CSF with a solubilizing agent, the oxidative refolding (first refolding step) of G-CSF in the presence of the solubilizing agent and an oxidizing agent, the efficient removal of the solubilizing agent, and a second refolding step to complete the folding of G-CSF in the absence of the solubilizing agent. Various methods are described for the efficient removal of the solubilizing agent from partially refolded G-CSF.
摘要:
Die vorliegende Erfindung betrifft ein Arzneimittel, das als Wirkstoffkombination wenigstens ein kontrazeptiv wirkendes Gestagen als einzige Hormonkomponente und wenigstens einen Insulinsensitizer enthält, das sich insbesondere zur Prophylaxe gegen oder zur Therapierung von krankhaften Störungen, die durch das Polyzystische Ovar-Syndrom (PCOS) verursacht werden, eignet.
摘要:
The present invention relates to a film-coated tablet containing drospirenone active agent, comprising a tablet core coated with a film-forming polymer layer with improved resistance against atmospheric humidity. The tablet core is obtainable by a process which comprises dissolving drospirenone in ethanol, then dripping the solution obtained onto the surface of the fluid bed in a fluidizing equipment without spraying pressure while controlling the temperature of the product obtained and removing the solvent molecules from the wet material by a hot airflow.
摘要:
Disclosed is a solid preparation for oral administration, which comprises cariprazine hydrochloride, in which lactose is used as the main excipient, and which enables the stable storage of cariprazine hydrochloride contained therein without the need of adding cyclodextrin.
摘要:
The present invention relates to use of (thio)-carbamoyl-cyclohexane derivatives, particularly trans-4- {2-[4-(2,3 -dichlorophenyl)-piperazin-1-yl] -ethyl} -N,N- dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment of schizophrenia. Furthermore, the present invention relates to the treatment of schizophrenia through the administration of (thio)- carbamoyl cyclohexane derivatives, particularly trans-4- {2-[4-(2,3-dichlorophenyl)-piperazin- 1-yl] -ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine and pharmaceutically acceptable salts thereof.
摘要:
The present invention relates to stable and bioavailable immediate release formulations comprising dopamine receptor ligands. Methods of treating various disorders by administering the formulations are also described.